Fil Ltd Denali Therapeutics Inc. (DNLI) insider trading activity

DNLI Quotes by TradingView

Fil LTD is of Denali Therapeutics Inc.. Currently has a direct ownership of 1.91 Million shares of DNLI, which is worth approximately $47.3 Million. The most recent transaction as insider was on Dec 12, 2017, when has been sold 1,497,951 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.91M
0% 3M change
0% 12M change
Total Value Held $47.3 Million

FIL Ltd Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2017
BUY
Conversion of derivative security
-
1,497,951 Added 43.89%
1,914,833 Common Stock

Also insider at

COGT
Cogent Biosciences, Inc. Healthcare
SURF
Surface Oncology, Inc. Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
GPCR
Structure Therapeutics Inc.
BCAX
Bicara Therapeutics Inc.
FL

Fil LTD

Hamilton, D0

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNLI